Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Gsk (GLAXF) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Gsk (GLAXF) over the last 17 years, with Q4 2025 value amounting to -$54.5 million.

  • Gsk's Exchange Rate Effect fell 13631.32% to -$54.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$23.5 million, marking a year-over-year decrease of 13270.09%. This contributed to the annual value of -$25.1 million for FY2025, which is 6370.12% up from last year.
  • As of Q4 2025, Gsk's Exchange Rate Effect stood at -$54.5 million, which was down 13631.32% from $79.6 million recorded in Q3 2025.
  • Over the past 5 years, Gsk's Exchange Rate Effect peaked at $687.6 million during Q4 2023, and registered a low of -$1.8 billion during Q4 2022.
  • For the 5-year period, Gsk's Exchange Rate Effect averaged around -$54.1 million, with its median value being -$12.0 million (2024).
  • Examining YoY changes over the last 5 years, Gsk's Exchange Rate Effect showed a top increase of 629690.2% in 2022 and a maximum decrease of 381809.0% in 2022.
  • Over the past 5 years, Gsk's Exchange Rate Effect (Quarter) stood at -$45.8 million in 2021, then tumbled by 3818.09% to -$1.8 billion in 2022, then skyrocketed by 138.29% to $687.6 million in 2023, then tumbled by 78.16% to $150.2 million in 2024, then tumbled by 136.31% to -$54.5 million in 2025.
  • Its Exchange Rate Effect stands at -$54.5 million for Q4 2025, versus $79.6 million for Q3 2025 and -$34.7 million for Q2 2025.